S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.

Weiping Jia, X-J Gao, Zhang Zd, Yang Zx, G Zhang

PubMed · 2013 · 61 citations · 37 references

Abstract

Our results provide evidence that the downregulation of S100A4 using RNAi technology may provide an effective tool for thyroid cancer therapy.

References

37